BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29378199)

  • 1. Iron-induced oxidative stress stimulates osteoclast differentiation via NF-κB signaling pathway in mouse model.
    Wang X; Chen B; Sun J; Jiang Y; Zhang H; Zhang P; Fei B; Xu Y
    Metabolism; 2018 Jun; 83():167-176. PubMed ID: 29378199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.
    Wang L; Qiu XM; Gui YY; Xu YP; Gober HJ; Li DJ
    Drug Des Devel Ther; 2015; 9():3755-66. PubMed ID: 26229438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass.
    Xiao W; Beibei F; Guangsi S; Yu J; Wen Z; Xi H; Youjia X
    J Endocrinol; 2015 Sep; 226(3):121-34. PubMed ID: 26116610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-κB and mitogen-activated protein kinase pathways.
    Tzeng HE; Tsai CH; Ho TY; Hsieh CT; Chou SC; Lee YJ; Tsay GJ; Huang PH; Wu YY
    BMC Complement Altern Med; 2018 Apr; 18(1):132. PubMed ID: 29688864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H; Zhao L; Cao H; Chen A; Xiao J
    FASEB J; 2015 Mar; 29(3):1092-101. PubMed ID: 25466887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
    Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation.
    Koh JM; Lee YS; Kim YS; Kim DJ; Kim HH; Park JY; Lee KU; Kim GS
    J Bone Miner Res; 2006 Jul; 21(7):1003-11. PubMed ID: 16813521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crocin inhibits RANKL-induced osteoclast formation and bone resorption by suppressing NF-κB signaling pathway activation.
    Fu L; Pan F; Jiao Y
    Immunobiology; 2017 Apr; 222(4):597-603. PubMed ID: 27871781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo.
    Yokota K; Sato K; Miyazaki T; Kitaura H; Kayama H; Miyoshi F; Araki Y; Akiyama Y; Takeda K; Mimura T
    Arthritis Rheumatol; 2014 Jan; 66(1):121-9. PubMed ID: 24431283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species.
    Jia P; Xu YJ; Zhang ZL; Li K; Li B; Zhang W; Yang H
    J Orthop Res; 2012 Nov; 30(11):1843-52. PubMed ID: 22570238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoclast differentiation regulated by receptor activator of nuclear factor kappaB probably through a novel signaling pathway].
    Xu DR; Chen HZ; Wang HH; Li J; Luo SK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):607-11. PubMed ID: 19549373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.